Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16M Buy
14,252
+12,237
+607% +$4.19M 0.54% 42
2026
Q1
$709K Sell
2,015
-76
-4% -$27.1K 0.23% 83
2025
Q4
$684K Buy
2,091
+36
+2% +$11.4K 0.19% 88
2025
Q3
$580K Sell
2,055
-31
-1% -$8.99K 0.2% 87
2025
Q2
$582K Buy
2,086
+103
+5% +$29.2K 0.22% 87
2025
Q1
$618K Buy
+1,983
New +$586K 0.27% 75
2024
Q4
Sell
-1,682
Closed -$542K 92
2024
Q3
$542K Buy
+1,682
New +$550K 0.3% 66

Other funds holding AMGN

Elyxium Wealth's AMGN Position: Q2 2026 in Review

Elyxium Wealth increased its Amgen (AMGN) stake by 607% in Q2 2026, buying an estimated $4.19M and bringing the position to 14,252 shares worth $5.16M. The position accounts for 0.54% of the portfolio, ranked #42.

Elyxium Wealth first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Elyxium Wealth held 14,252 shares of Amgen worth $5.16M as of Q2 2026.
  • Elyxium Wealth bought 12,237 Amgen shares in Q2 2026, an estimated $4.19M.
  • Amgen made up 0.54% of Elyxium Wealth's portfolio in Q2 2026, its #42 holding.
  • Elyxium Wealth first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.